Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Crescita Therapeutics Inc CRRTF


Primary Symbol: T.CTX

Crescita Therapeutics Inc. is a commercial dermatology company with in-house research and development (R&D) and manufacturing capabilities. It offers a portfolio of science-based non-prescription skincare products and early to commercial stage prescription products. It operates in three segments: Commercial Skincare, Licensing and Royalties and Manufacturing and Services. The Commercial... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (TSX:CTX)

No current opinion is available.

Bullboard Posts (TSX:CTX)

Q4 on sedar

Skincare biz growing. Looking for new customers for their contract manufacturing biz where the plant has a capacity of $25 mil/yr. ...
lscfa - March 15, 2024

RE:NCAV = $0.637/share

Cash/share = $0.47 and cash flow positive biz
lscfa - March 15, 2024

NCAV = $0.637/share

After the release of financials this week I'm seeing NCAV at $0.637/share. Despite struggles in their manufacturing segment this...
Stonksonlyup90 - March 13, 2024

RE:RE:RE:RE:Net-Net Stock - cheap stock

Management knew a while ago the Taro deal was done and dead. There was no proactive steps taken by them at all. This company is done...
daydream1 - November 9, 2023

RE:RE:RE:Net-Net Stock - cheap stock

So much for the down side being limited. Disastrous Q3 results released today.
drewmumaw - November 8, 2023

RE:RE:Net-Net Stock - cheap stock

I agree totally with your comments Drewmumaw.  You nailed down the issue with this company.  As Warren Buffet said it many...
stef1234 - October 4, 2023